1 – 10 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Drug-Induced Cognitive Impairment
- Contribution to journal › Scientific review
-
Mark
Gene therapy in advanced metachromatic leukodystrophy : tempering expectations
- Contribution to journal › Debate/Note/Editorial
-
Mark
Chemogenetics with PSAM4-GlyR decreases excitability and epileptiform activity in epileptic hippocampus
- Contribution to journal › Article
-
Mark
An interview with Ondřej Strýček, 2025 Epilepsia Open prize winner for clinical research
- Contribution to journal › Debate/Note/Editorial
-
Mark
Validating the PECARN rule to identify febrile infants at low risk of serious bacterial infections : an international validation study
(2025) In Archives of Disease in Childhood
- Contribution to journal › Article
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
- Contribution to journal › Article
-
Mark
Acute Postoperative Seizures are a Negative Prognostic Factor for Seizure Freedom After Epilepsy Surgery for Focal Cortical Dysplasia
- Contribution to journal › Article
-
Mark
Personality Trait Changes After Device-Aided Therapy : Insights From Parkinson’s Patients and Their Close Relatives
- Contribution to journal › Article
-
Mark
Authors’ reply to Chaker Ben Salem’s comment on : “Drug-Induced Cognitive Impairment”
- Contribution to journal › Letter
-
Mark
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype : study protocol for a randomized double-blind placebo-controlled trial
- Contribution to journal › Article
